Science Corporation stories

Jul 22, 2026

Science Corp’s PRIMA Retinal Implant Receives CE Mark for European Commercial Launch

Science Corporation has received CE mark approval and begun commercial launch in Europe of PRIMA, a retinal implant that restores functional central vision to patients with geographic atrophy caused by age-related macular degeneration. The device could launch in the U.S. in 2027.

Jul 22, 20264 sources

00

Featured Stories

OpenAI pauses development of Astra AI model over critical cybersecurity capability concerns

Aug 7, 20262 sources